M. C. Monge B.

A phase I study of GPC3 targeted CAR-T cell therapy in advanced GPC3-expressing hepatocellular carcinoma (HCC).

Brad J. Wood, Mitchell Ho, T. Greten, 2023, Journal of Clinical Oncology.